Parents often say that the moment they first hear their child has leukemia, their mind just goes blank. The doctor explains this and that, but half of it never really registers, and it's only back home that you find yourself thinking, "Wait, what exactly did they say our child has?" and start searching all over again. So today I've tried to lay out, step by step, the broad ways childhood leukemia is divided and the order in which treatment unfolds, putting the hard medical terms into plain words as much as I can.
Leukemia, in a nutshell, is a disease in which abnormal cells multiply out of control in the bone marrow, the tissue that makes our blood. In children it splits into two main branches. When it arises from the lymphocyte line of immune cells, it's called acute lymphoblastic leukemia (ALL); when it comes from the myeloid cell line, it's called acute myeloid leukemia (AML). In children, ALL is far more common. Of every ten children diagnosed with leukemia, roughly seven or eight have ALL. The two may sound alike, but their treatment approaches, the drugs used, and the duration are all quite different, so figuring out from the start which one it is really matters.
So how do they tell the types apart? At first, abnormal numbers show up in a blood test, and ultimately a bone marrow exam confirms the diagnosis. A little marrow is drawn from the hip bone, and the cells inside are examined under a microscope, looking at which markers sit on their surface (the immunophenotype) and what changes have occurred in the chromosomes and genes. These days this genetic information isn't just for classification, it has become the key yardstick for deciding "this child is high-risk and needs stronger treatment" or "a lighter approach is fine." Even within ALL, the type of genetic mutation determines whether a child falls into the standard-risk or high-risk group, and the intensity of treatment is adjusted accordingly.
Treatment usually proceeds in stages. Taking ALL as an example, the first month or so is called induction, the period when the leukemia cells in the body are driven down as quickly as possible. When the cancer cells in the marrow shrink to the point of being barely visible, the child is said to have entered "remission." Next comes consolidation, followed by prophylactic treatment to prevent spread to the central nervous system (such as chemotherapy injected into the spinal canal). Finally, it wraps up with maintenance therapy, taking relatively mild medication for up to around two years to keep relapse at bay. The whole span feels long, but this long-tailed maintenance phase plays a fairly important role in preventing relapse. AML, by contrast, leans toward shorter, stronger bursts of chemotherapy repeated intensively, and when the risk is high or the chance of relapse is large, a stem cell transplant may be considered.
For parents, the question that matters most in the end is, "Can my child be cured?" Fortunately, childhood ALL is one of the cancers whose treatment outcomes have improved a great deal. Of course, every child differs in type, risk level, and response to treatment, so it can't be summed up in a single line. During treatment, immunity drops sharply, so managing infection is genuinely important, and the everyday care of staying by a child who has lost their appetite and feels weak counts for as much as the medicine itself. Caregivers inevitably get worn down too, so reaching out early to family support groups walking the same road or to the hospital's social work team makes it all feel a lot less lonely.
What's written here is a general overview meant to help you grasp the big picture. Please talk things through fully with your child's doctor to settle on your child's exact type and treatment plan.